La cadena de opciones muestra datos clave de las opciones de acciones de Akoya Biosciences a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Akoya Biosciences..

Akoya Biosciences (NASDAQ:AKYA) Bolsa, Cadena de Opciones

Akoya Biosciences

Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.

Akoya Biosciences Inc

Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) shares are trading higher today.
On Wednesday, the company renewed its partnership with Churchill Downs Racetrack as the exclusive automotive partner of the Kentucky <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44398200/ford-named-exclusive-automotive-partner-of-the-kentucky-derby-in-multi-year-partnership-extension" rel="noreferrer noopener">Derby presented by Woodford Reserve</a>.
Under the multi-year deal extending through 2029, Ford will expand its presence at Churchill Downs by securing naming rights to the First Turn Club, now officially the Ford First Turn Club.
This extended collaboration grants Ford category exclusivity and an expanded presence with interactive vehicle displays to enhance fan engagement during Derby Week and beyond.
Related Read: <a target="_blank" href="https://www.benzinga.com//node/44390358" rel="noreferrer noopener">Elon Musk Calls It &#8216;Extreme Domestic Terrorism&#8217; After Website Publishes Data On US Tesla Owners</a>
Additionally, Ford will showcase exclusive luxury vehicle displays and new Ford-themed fan experiences at key locations, including the Paddock Plaza and VIP Gate, ensuring strong brand visibility throughout Derby Week.
Ford will continue its sponsorship of key Kentucky Derby and Oaks activations, including branding on the Derby Starting Gate, presenting sponsorship of the Churchill Downs Barn Area, a Derby Day race entitlement, exclusive digital content, and year-round vehicle displays at Churchill Downs.
Phil O&#8217;Connor, director of global marketing communications – Ford Blue and Model e at Ford Motor Company said, &#8220;Ford&nbsp;has a deep connection with the&nbsp;Louisville&nbsp;community. Our&nbsp;Louisville-based manufacturing facilities employ roughly 12,000 Kentuckians.&#8221;
&#8221;Our heritage of capability, passion and innovation make our friends at Churchill Downs Racetrack ideal partners. We&#8217;re excited for this next chapter in our partnership and honored to continue supporting the bluegrass state.&#8221;
Earlier this month, Ford Pro partnered with Work Truck Solutions to introduce an online tool that helps customers easily find road- and work-ready trucks <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44149002/work-truck-solutions-announces-collaboration-with-ford-pro-to-power-commercial-vehicle-locator" rel="noreferrer noopener">and vans in Ford dealer inventory</a>.
Investors can gain exposure to the stock via&nbsp;First Trust Nasdaq Transportation ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXR#NASDAQ">FTXR</a>).
Price Action: F shares are up 0.91% at $10.05 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/econ-s/25/03/44262286/tariff-uncertainty-poses-major-risk-to-us-automakers-how-much-could-ford-gm-earnings-fall" target="_blank" rel="noreferrer noopener">Tariff Uncertainty Poses Major Risk To US Automakers: How Much Could Ford, GM Earnings Fall?</a></li>
</ul>
Photo via Shutterstock.

Equities

Large Cap

News

Contracts

FTXR

Ford Renews Exclusive Partnership with Kentucky Derby, Expands Brand Presence Through 2029

WIIM

INTC

Intel shares are trading lower, pulling back after gaining recently on new CEO optimism.

NVDA

NVIDIA shares are trading higher amid the company's GTC Conference this week.

GILD

Gilead Sciences shares are trading lower after reports indicating the Trump administration is considering cuts to domestic HIV prevention programs.

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) with a Buy and maintains $60 price target.

Price Target

Reiteration

Analyst Ratings

DTIL

HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price Target

HC Wainwright &amp; Co. analyst Emily Bodnar maintains Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) with a Buy and raises the price target from $12 to $15.

FEMY

HC Wainwright & Co. Maintains Buy on Femasys, Raises Price Target to $15

Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) near-term trajectory and dynamic regarding Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) will depend on technical indicators and the outcome of Wednesday&#8217;s Federal Open Market Committee decision, according to <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44377385/bitcoin-remains-stuck-in-the-low-80000s-what-does-technical-analysis-say">prominent analyst Benjamin Cowen</a>.
What Happened: In a <a href="https://www.youtube.com/watch?v=T8BQXl7PcJ4">podcast</a> published on Tuesday, Cowen identified Bitcoin&#8217;s weekly Relative Strength Index (RSI) support level having hit the 44 level for the third time in this cycle, after previous touches in September 2023 and September 2024.
If BTC holds this level, it would align with the 2016-2017 bull cycle. 
A break below 44 RSI, however, could mean the market resembles 2019-2020's choppier period instead.
Cowen noted that while 2016-2017 had risk-on periods in February, this cycle has remained risk-off through January, February and March, raising concerns about market strength.
Also Read: <a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44398922/the-bitcoin-fomc-preview-a-dovish-powell-pivot-could-send-btc-to-90000">The Bitcoin FOMC Preview: A Dovish Powell Pivot Could Send BTC To $90,000</a>
What's Next: In another <a href="https://www.youtube.com/watch?v=UdtpOP_uBc0">podcast</a>, Cowen examined the impact of Federal Reserve policy on crypto markets, particularly Ethereum.
He commented on the Federal Reserve's upcoming policy decision, suggesting the continuation of quantitative tightening has significantly impacted market dynamics, particularly for altcoins.
The last time ETH was at ~$1,800 (2022), Bitcoin traded around $20,000-$25,000. 
Now, Bitcoin is nearly 4x higher, but ETH has remained at the same price, indicating altcoins are lagging BTC significantly.
Looking ahead to the FOMC meeting, Cowen noted that if quantitative tightening ends, historical patterns suggest ETH/BTC would bounce, similar to previous cycles.
Inflation concerns could delay a Fed pivot, making a rapid recovery uncertain. 
&#8220;They might not be as willing to support markets in the same way as quickly until it&#8217;s more apparent that inflation is actually coming back down to earth,&#8221; Cowen said.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44383822/bitcoin-drops-16-in-a-month-are-bear-market-signals-flashing">Bitcoin Drops 16% In A Month: Are Bear Market Signals Flashing?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

Bitcoin, Ethereum Face Uncertain Future: What Do Technical Indicators Say?

CAAP

Corporacion America Airports shares are trading lower after the company reported a Q4 GAAP EPS miss.

Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) stock is on the verge of forming <a href="https://www.benzinga.com/topic/death-cross">a Death Cross</a>, which is a bearish technical signal that occurs when the 50-day simple moving average (SMA) falls below the 200-day SMA.
While Nvidia stock has been riding high on AI-driven optimism, the charts suggest a different story &#8211; one that investors can't afford to ignore.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="618" height="487" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19104618/Screenshot-2025-03-19-at-8.01.51-PM.png" alt="" class="wp-image-831842" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19104618/Screenshot-2025-03-19-at-8.01.51-PM.png 618w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/19104618/Screenshot-2025-03-19-at-8.01.51-PM-300x236.png 300w" sizes="(max-width: 618px) 100vw, 618px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
<h2 class="wp-block-heading">Nvidia Stock Chart Flashing Bearish Signals</h2>
Nvidia stock is below its 20-day, 50-day and 200-day SMAs, indicating strong selling pressure. While the eight-day SMA lies below stock giving some support, the 20-day SMA at $119.96 and 50-day SMA at $128.00 are all trending above Nvidia stock at $117.19, reinforcing the bearish momentum.
Additionally, the 200-day SMA at $127.70 suggests that Nvidia stock is struggling to hold long-term support levels.
Momentum indicators also paint a concerning picture. The Moving Average Convergence Divergence (MACD) sits at a negative 3.76, a bearish signal, while the Relative Strength Index (RSI) of 45.84 shows weakening buying strength.
Read Also: <a href="https://www.benzinga.com/news/large-cap/25/03/44396572/nvidia-introduces-new-ai-and-robotics-tools-at-gtc-powering-the-future-of-technology">NVIDIA Introduces New AI And Robotics Tools At GTC, Powering The Future Of Technology</a>
<h2 class="wp-block-heading">Buy The Dip Or Brace For More Pain?</h2>
While Nvidia's long-term AI narrative remains intact, bolstered by breakthroughs unveiled at GTC 2025, including the Blackwell Ultra GPU series and AI-powered robotics, the current technical setup suggests short-term downside risk.
For short-term traders, a death cross typically signals continued weakness, meaning Nvidia could face further selling pressure before stabilizing. 
For long-term investors, this could present a buying opportunity if Nvidia finds support and rebounds. However, given that previous death crosses have sometimes preceded extended declines, caution is warranted.
With Nvidia still commanding AI dominance but facing a battle between technical weakness and fundamental strength, investors must decide: Is this a dip worth buying or a warning sign to stay cautious?
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44396940/nvidias-ai-reign-extends-to-2028-jpmorgan-says-its-still-1-2-steps-ahead">Nvidia Extends AI Reign To 2028: JPMorgan Says It&#8217;s Still &#8216;1-2 Steps Ahead&#8217;</a></li>
</ul>
Photo: Shutterstock

Technicals

Signals

Tech

Trading Ideas

Nvidia Stock Nears A Death Cross - Can The GTC AI Hype Save It?

Craig-Hallum analyst Chase Knickerbocker maintains Eton Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETON#NASDAQ">ETON</a>) with a Buy and raises the price target from $23 to $26.

ETON

Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $26

Whales with a lot of money to spend have taken a noticeably bearish stance on NextEra Energy.
Looking at options history for NextEra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with bullish expectations and 75% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $300,085 and 2, calls, for a total amount of $87,950.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $70.0 and $75.0 for NextEra Energy, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for NextEra Energy's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across NextEra Energy's significant trades, within a strike price range of $70.0 to $75.0, over the past month.
<h3>NextEra Energy Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742400946_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.92</td>
<td>$1.8</td>
<td>$1.92</td>
<td>$70.00</td>
<td>$96.0K</td>
<td>5.6K</td>
<td align="right">528</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$6.5</td>
<td>$6.4</td>
<td>$6.5</td>
<td>$72.50</td>
<td>$53.3K</td>
<td>876</td>
<td align="right">83</td>
</tr>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.97</td>
<td>$1.83</td>
<td>$1.92</td>
<td>$70.00</td>
<td>$51.6K</td>
<td>5.6K</td>
<td align="right">760</td>
</tr>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$7.9</td>
<td>$7.8</td>
<td>$7.9</td>
<td>$75.00</td>
<td>$45.8K</td>
<td>36</td>
<td align="right">58</td>
</tr>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.92</td>
<td>$1.82</td>
<td>$1.92</td>
<td>$70.00</td>
<td>$44.5K</td>
<td>5.6K</td>
<td align="right">760</td>
</tr>
</tbody>
</table>

<h3>About NextEra Energy</h3>
NextEra Energy's regulated utility, Florida Power &amp; Light, is the largest rate-regulated utility in Florida. The utility distributes power to nearly 6 million customer accounts in Florida and owns 34 gigawatts of generation. FP&amp;L contributes roughly 70% of NextEra's consolidated operating earnings. NextEra Energy Resources, the renewable energy segment, generates and sells power throughout the United States and Canada with more than 34 GW of generation capacity, including natural gas, nuclear, wind, and solar.
<h3>Present Market Standing of NextEra Energy</h3>
<ul>
<li>With a trading volume of 2,398,309, the price of NEE is down by -0.43%, reaching $70.39.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 34 days from now.</li>
</ul>
<h3>Expert Opinions on NextEra Energy</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $91.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for NextEra Energy, targeting a price of $91. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for NextEra Energy with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Markets

Spotlight on NextEra Energy: Analyzing the Surge in Options Activity

Investors with a lot of money to spend have taken a bearish stance on Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 19 uncommon options trades for Philip Morris Intl.
This isn't normal.
The overall sentiment of these big-money traders is split between 36% bullish and 42%, bearish.
Out of all of the special options we uncovered, 14 are puts, for a total amount of $1,500,308, and 5 are calls, for a total amount of $261,660.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $140.0 and $170.0 for Philip Morris Intl, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Philip Morris Intl's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Philip Morris Intl's significant trades, within a strike price range of $140.0 to $170.0, over the past month.
<h3>Philip Morris Intl Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742400942_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.5</td>
<td>$5.3</td>
<td>$5.45</td>
<td>$150.00</td>
<td>$408.7K</td>
<td>702</td>
<td align="right">833</td>
</tr>
<tr>
<td>PM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$12.9</td>
<td>$12.7</td>
<td>$12.7</td>
<td>$165.00</td>
<td>$127.0K</td>
<td>691</td>
<td align="right">100</td>
</tr>
<tr>
<td>PM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$7.8</td>
<td>$7.6</td>
<td>$7.8</td>
<td>$155.00</td>
<td>$100.6K</td>
<td>1.1K</td>
<td align="right">151</td>
</tr>
<tr>
<td>PM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$10.7</td>
<td>$10.5</td>
<td>$10.67</td>
<td>$160.00</td>
<td>$100.5K</td>
<td>363</td>
<td align="right">188</td>
</tr>
<tr>
<td>PM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$14.1</td>
<td>$13.9</td>
<td>$14.04</td>
<td>$165.00</td>
<td>$99.8K</td>
<td>149</td>
<td align="right">71</td>
</tr>
</tbody>
</table>

<h3>About Philip Morris Intl</h3>
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.
Having examined the options trading patterns of Philip Morris Intl, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Philip Morris Intl's Current Market Status</h3>
<ul>
<li>Trading volume stands at 1,119,755, with PM's price up by 0.38%, positioned at $154.43.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 35 days.</li>
</ul>
<h3>What The Experts Say On Philip Morris Intl</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $167.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Philip Morris Intl with a target price of $175. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Philip Morris Intl, which currently sits at a price target of $160. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Philip Morris Intl, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Unpacking the Latest Options Trading Trends in Philip Morris Intl

Deep-pocketed investors have adopted a bullish approach towards Vertiv Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VRT usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 25 extraordinary options activities for Vertiv Holdings. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 40% leaning bullish and 32% bearish. Among these notable options, 15 are puts, totaling $968,812, and 10 are calls, amounting to $853,830.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $50.0 to $125.0 for Vertiv Holdings over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Vertiv Holdings stands at 457.88, with a total volume reaching 3,898.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Vertiv Holdings, situated within the strike price corridor from $50.0 to $125.0, throughout the last 30 days.
<h3>Vertiv Holdings Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742400937_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VRT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$10.6</td>
<td>$10.55</td>
<td>$10.6</td>
<td>$120.00</td>
<td>$233.2K</td>
<td>1.0K</td>
<td align="right">227</td>
</tr>
<tr>
<td>VRT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$8.55</td>
<td>$8.5</td>
<td>$8.55</td>
<td>$100.00</td>
<td>$165.8K</td>
<td>1.0K</td>
<td align="right">199</td>
</tr>
<tr>
<td>VRT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$12.5</td>
<td>$12.4</td>
<td>$12.5</td>
<td>$87.50</td>
<td>$146.2K</td>
<td>572</td>
<td align="right">123</td>
</tr>
<tr>
<td>VRT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$12.5</td>
<td>$12.4</td>
<td>$12.5</td>
<td>$87.50</td>
<td>$130.0K</td>
<td>572</td>
<td align="right">216</td>
</tr>
<tr>
<td>VRT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$39.5</td>
<td>$39.15</td>
<td>$39.32</td>
<td>$125.00</td>
<td>$117.8K</td>
<td>669</td>
<td align="right">74</td>
</tr>
</tbody>
</table>

<h3>About Vertiv Holdings</h3>
Vertiv has roots tracing back to 1946 when its founder, Ralph Liebert, developed an air-cooling system for mainframe data rooms. As computers started making their way into commercial applications in 1965, Liebert developed one of the first computer room air conditioning, or CRAC, units, enabling the precise control of temperature and humidity. The firm has slowly expanded its data center portfolio through internal product development and the acquisition of thermal and power management products like condensers, busways, and switches. Vertiv has global operations today; its products can be found in data centers in most regions throughout the world.
In light of the recent options history for Vertiv Holdings, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Vertiv Holdings's Current Market Status</h3>
<ul>
<li>With a trading volume of 2,261,911, the price of VRT is up by 3.87%, reaching $87.93.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 35 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Vertiv Holdings</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $116.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $121. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Vertiv Holdings, targeting a price of $111. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Vertiv Holdings with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Vertiv Holdings Unusual Options Activity

Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) has outperformed the market over the past 10 years by 10.95% on an annualized basis producing an average annual return of 21.44%. Currently, Arthur J. Gallagher has a market capitalization of $83.96 billion. 
Buying $1000 In AJG: If an investor had bought $1000 of AJG stock 10 years ago, it would be worth $6,923.73 today based on a price of $329.66 for AJG at the time of writing.
<h3>Arthur J. Gallagher's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742400910_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

ALLO

Allogene Therapeutics shares are trading lower after HC Wainwright & Co. cut its price target on the stock from $9 to $8.

Oil prices fell 1% Tuesday with geopolitical change and economic uncertainty contributing to market expectations. 
<a href="https://www.benzinga.com/news/global/25/03/44384160/oil-prices-slip-energy-stocks-pause-as-trump-putin-call-signals-ukraine-ceasefire-progress">Diplomatic talks between</a> U.S. President Donald Trump and Russian President Vladimir Putin encouraged the prospect of a Ukraine ceasefire that might relax sanctions on Russian fuel exports, according to Reuters. But analysts warn it will take time for a meaningful recovery in Russian oil output. While this is, at least in part, due to the effects of Trump&#8217;s trade tariffs on energy demand, there are a number of other factors coming into play. These combine to create a complicated energy scenario, making <a href="https://www.benzinga.com/etfs">energy ETFs</a> a focal point of investor interest.
<h1 class="wp-block-heading">How Energy ETFs Fit Into The Picture</h1>
ETFs provide exposure to the energy sector with risk management against changing oil prices and geopolitical events. Here&#8217;s how various kinds of energy ETFs could be impacted:
Diversified Energy ETFs: These offer diversified exposure to exploration, production, refining and transport, enabling investors to control volatility. Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) and the iShares U.S. Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYE#NYSE">IYE</a>) are options to consider, with expense ratios of 0.08% and 0.4%, respectively.
Exploration and Production (E&amp;P) ETFs: Concentrated on extracting oil and gas, these ETFs can experience volatility due to changes in supply and demand. Investors may look at the SPDR S&amp;P Oil &amp; Gas Exploration &amp; Production ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOP#NYSE">XOP</a>) and the iShares U.S. Oil &amp; Gas Exploration &amp; Production ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IEO#BATS">IEO</a>). The ETFs carry an expense ratio of 0.35% and 0.4%, respectively.
Midstream ETFs: Comprising less price-volatile components, these may be rewarded with higher oil transport and storage requirements. Examples include the Alerian MLP ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMLP#NYSE">AMLP</a>) and the Global X MLP ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLPA#NYSE">MLPA</a>), with expense ratios of 0.85% and 0.45%, respectively.
Also Read: <a href="https://www.benzinga.com/25/03/44217245/us-shale-industry-set-to-boost-oil-output-despite-falling-prices-says-energy-secretary-the-economics-of-shale-dont-work-says-expert">US Shale Industry Can Deliver Trump&#8217;s Pledge For &#8216;Drill, Baby, Drill&#8217; Despite Falling Prices, Says Energy Secretary: &#8216;The Economics Of Shale Don&#8217;t Work,&#8217; Says Expert</a>
<h1 class="wp-block-heading">Contributing Factors To Slowing Oil Prices</h1>
• If sanctions against Russia are relaxed, its crude output — presently at 9.2 million barrels per day (bpd), from 10.6 million bpd in 2016 — might rise. But significant supply shifts might not be immediate, per the Reuters report.
• Trump's tariffs are pressuring global growth. The OECD warns of slower growth, while Wood Mackenzie cut its 2025 Brent crude forecast by $7 to $73 per barrel, according to Reuters.
• OPEC+ is going ahead with its scheduled April output increase, pumping additional supply into the market.
• Middle East uncertainty is another underpinning factor in oil prices. Trump&#8217;s military intervention in support of Iran-aligned Houthis in Yemen and Israeli airstrikes on Gaza inject volatility into the global oil supply.
• Chinese and German economic stimulus may be able to sustain oil demand, offsetting some of the pressure on prices lower.
• This week, the American Petroleum Institute (API) and U.S. Energy Information Administration (EIA) will report on oil inventories. Reuters reported that a 0.9 million barrel build is expected by analysts, which may have an impact on short-term price action.
Oil prices continue to be very volatile based on geopolitical and economic reasons. Energy ETFs provide investors with the means to ride out these changes, managing risk while achieving opportunity. Monitoring worldwide trends and inventory reports will be paramount in making smart investment decisions.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/03/44382780/3-best-performing-semiconductor-etfs-since-last-gtc-and-why-this-time-is-different">3 Best-Performing Semiconductor ETFs Since Last GTC And Why This Time Is Different</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

Commodities

Global

ETFs

AMLP

iShares Dow Jones US Oil & Gas Exploration & Production Index Fund

iShares Dow Jones US Energy Sector Index Fund

MLPA

Oil Prices Ease: What It Means For Energy ETFs, Investors

Bakkt Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKKT#NYSE">BKKT</a>) shares are down 29% to $9.04 since Tuesday&#8217;s open after the company revealed that it lost crucial commercial agreements, a setback expected to <a href="https://www.benzinga.com/news/25/03/44380083/why-bakkt-bkkt-shares-are-getting-hammered">negatively impact its revenue</a>.
What Happened: In an <a href="https://d18rn0p25nwr6d.cloudfront.net/CIK-0001820302/8b57c744-6587-490b-8040-31d7ca183246.pdf">SEC filing</a> on Monday, Bakkt disclosed that both Bank of America and Webull Pay LLC have opted not to renew their commercial agreements with the company. These partnerships were integral to Bakkt's revenue streams, making their impending expiration a financial blow.
The Bank of America contract, which contributes approximately 16-17% of Bakkt&#8217;s loyalty services revenue, is set to expire on April 22. However, the company noted that a transition period of up to 12 months may follow, potentially softening the immediate impact.
Read Also: <a href="https://www.benzinga.com/25/03/44396940/nvidias-ai-reign-extends-to-2028-jpmorgan-says-its-still-1-2-steps-ahead">Nvidia Extends AI Reign To 2028: JPMorgan Says It&#8217;s Still &#8216;1-2 Steps Ahead&#8217;</a>
On the other hand, Webull&#8217;s agreement, which accounts for 74% of Bakkt&#8217;s crypto services revenue, will officially end on June 14, 2025. 
The termination of this partnership is particularly concerning as it could dramatically weaken Bakkt's position in the cryptocurrency sector.
The loss of these agreements raises concerns about Bakkt's future revenue prospects, especially within its crypto services segment.
Read Also: <a href="https://www.benzinga.com/real-estate/reit/25/03/44396973/mortgage-applications-drop-as-rising-rates-squeeze-refinance-demand">Mortgage Applications Drop As Rising Rates Squeeze Refinance Demand</a>
<h2 class="wp-block-heading">How To Buy BKKT Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Bakkt&#8217;s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BKKT has a 52-week high of $37.21 and a 52-week low of $5.57.

Bakkt Holdings, Inc. Class A Common Stock

BKKT

Why Bakkt (BKKT) Stock Is Volatile This Week

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 200 points on Wednesday.
The Dow traded up 0.55% to 41,808.59 while the NASDAQ climbed 0.95% to 17,671.26. The S&amp;P 500 also rose, gaining, 0.66% to 5,651.61.
Check This Out: <a href="https://www.benzinga.com/25/03/44396179/how-to-earn-500-a-month-from-jabil-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Jabil Stock Ahead Of Q2 Earnings</a>
Leading and Lagging Sectors Energy shares rose by 1.2% on Wednesday.
In trading on Wednesday, real estate shares fell by 0.7%.
Top Headline
The EIA said crude oil inventories in the US increased by 1.745 million barrels in the week ended March 14, compared to market estimates of a 1.1 million gain.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Service Properties Trust &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVC#NASDAQ">SVC</a>) shares shot up 18% to $2.94 after Wells Fargo upgraded the stock from Underweight to Overweight and raised its price target from $2.5 to $4.</li>
<li>Shares of Aterian, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>)got a boost, surging 31% to $2.7640 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>BGM Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGM#NASDAQ">BGM</a>) shares were also up, gaining 16% to $11.79 after the company announced the acquisition of YX for $95 million.</li>
</ul>
Equities Trading DOWN
<ul>
<li>HealthEquity, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) shares dropped 18% to $83.35 after the company reported worse-than-expected fourth-quarter adjusted EPS results.</li>
<li>Shares of Organovo Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) were down 30% to $0.2815 after the company announced a 1-for-12 reverse stock split.</li>
<li>OmniAb, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OABI#NASDAQ">OABI</a>) was down, falling 17% to $2.6545 following fourth-quarter earnings.</li>
</ul>
Commodities In commodity news, oil traded up 0.7% to $67.38 while gold traded down 0.1% at $3,040.50.
Silver traded down 1.6% to $34.275 on Wednesday, while copper rose 1.2% to $5.0765.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.12%, Germany's DAX 40 fell 0.55% and France's CAC 40 gained 0.65%. Spain's IBEX 35 Index rose 0.30%, while London's FTSE 100 rose 0.08%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei falling 0.25%, China's Shanghai Composite Index falling 0.1%, Hong Kong's Hang Seng Index gaining 0.12% and India's BSE Sensex gaining 0.20%.
Economics
<ul>
<li>U.S. mortgage applications declined by 6.2% in the second week of March, following a cumulative 37% increase from the two prior weeks.</li>
<li>The EIA said crude oil inventories in the US increased by 1.745 million barrels in the week ended March 14, compared to market estimates of a 1.1 million gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44396642/jim-cramer-says-tjx-is-terrific-recommends-buying-these-stocks">Jim Cramer Says TJX Is &#8216;Terrific,&#8217; Recommends Buying These Stocks</a></li>
</ul>

Earnings

Eurozone

Intraday Update

ATER

OABI

ONVO

Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected

On Wednesday, Hutchmed (China) Limited (NASDAQ: ​HCM) reported 2024 earnings of 22 cents per ADS or 4 cents per share, down 59 cents or 12 cents a year ago. Sales fell 25% year over <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">year to $630.20 million</a>.
Fruzaqla&#8217;s revenue was $110.8 million, and Elunate&#8217;s sales <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44394073/hutchmed-reports-2024-full-year-results-and-provides-business-updates" rel="noreferrer noopener">reached $86.3 million</a>.
Oncology product consolidated revenue&nbsp;increased 65% to $271.5 million, driven by Fruzaqla&nbsp;and&nbsp;exceeding 30% to 50% growth guidance.
Guidance: Hutchmed projects 2025 oncology/immunology consolidated revenue of $350 million–$450 million.
On Tuesday, Hutchmed (China) and Innovent Biologics, Inc. announced topline results from FRUSICA-2 Phase 2/3 trial of fruquintinib in combination with sintilimab as second-line treatment for locally advanced or metastatic renal (kidney) cell carcinoma in China.
The study met its primary endpoint of <a href="https://www.benzinga.com/pressreleases/25/03/g44389274/hutchmed-and-innovent-jointly-announce-that-the-frusica-2-phase-iiiii-study-of-fruquintinib-and-si" target="_blank" rel="noreferrer noopener">progression-free survival</a>.
Also Read: <a href="https://www.benzinga.com/news/earnings/25/03/44398289/gds-holdings-stock-slumps-after-q4-revenue-miss-ceo-highlights-ai-growth-potential" target="_blank" rel="noreferrer noopener">GDS Holdings Stock Slumps After Q4 Revenue Miss; CEO Highlights AI Growth Potential</a>
The combination of fruquintinib and sintilimab received conditional approval from the China National Medical Products Administration for advanced endometrial cancer with Mismatch Repair proficient (pMMR) tumors that have failed prior systemic therapy and are not candidates for curative surgery or radiation, based on data from the FRUSICA-1 study.
In addition to the primary endpoint progression-free survival, the combination also demonstrated improvements in secondary endpoints, including objective response rate and duration of response.
Fruquintinib is available as Elunate&nbsp;in China and as Fruzaqla&nbsp;outside of China.
In January, Hutchmed (China) entered into two agreements to divest its 45% equity interest in&nbsp;Shanghai Hutchison Pharmaceuticals Limited&nbsp;(SHPL) for approximately $608 million (RMB 4.478 billion) in cash to&nbsp;GP Health Service Capital Co., Ltd&nbsp;and&nbsp;Shanghai Pharmaceuticals Holding Co., Ltd.
These transactions would allow Hutchmed to focus on its core business of discovering, developing, and commercializing novel therapies for cancers and immunological diseases, including advancing its next-generation antibody-targeted <a target="_blank" href="https://www.benzinga.com/general/biotech/25/01/42762162/chinese-cancer-drug-developer-hutchmed-sharpens-rd-focus-divests-non-core-jv-for-over-600-million" rel="noreferrer noopener">therapy conjugate programs</a>.
Price Action: HCM stock is up 8.7% at $16.26 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44396181/general-mills-posts-a-5-decline-in-q4-sales-warns-of-continuing-economic-uncertainty" target="_blank" rel="noreferrer noopener">Pillsbury Maker General Mills Cautions About Economic Uncertainty After Q3 Revenue Dip</a></li>
</ul>
Photo: Shutterstock

Biotech

Guidance

Health Care

Movers

General

Hutchmed's Oncology Revenue Hits $271.5 Million, Rising 65% On Fruzaqla Strength

XHLD

Ten Holdings Shares Resume Trade

Press Releases

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

Comments

Akoya Biosciences

Akoya Biosciences (AKYA) Opciones

Akoya Biosciences (NASDAQ:AKYA) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL